Heart Rate Variability Biofeedback (HRV-BFB) Training
Heart Rate Variability Biofeedback (HRV-BFB) Training: Participants receive a structured heart rate variability biofeedback (HRV-BFB) training protocol delivered over 4 weeks. The intervention uses a portable chest-worn ECG sensor (eSense Pulse) connected via Bluetooth to a mobile application that provides real-time visual feedback of heart rate variability. Each participant completes 12 individual sessions of 12 minutes each (one session every 2 days). Sessions take place in a quiet room and follow a standardized format: a brief preparation phase, followed by approximately 10 minutes of guided breathing at resonance frequency (around 6 breaths per minute) using a visual breathing guide. The application displays color-coded feedback indicating how closely the participant's physiological response matches the target HRV pattern, and participants are instructed to adjust their breathing and recall positive memories to maximize time in the desired state. The aim is to increase HRV, strengthen parasympathetic activation, and improve stress and
Study summary
This exploratory study evaluates the effectiveness of a 12-session Heart Rate Variability Biofeedback (HRV-BFB) protocol in reducing distress and burnout while promoting psychological well-being among Portuguese National Republican Guard (GNR) professionals. Exposed to high occupational stress from unpredictable risks, shift work, and limited resources, these individuals face elevated vulnerability to chronic stress outcomes. The intervention leverages real-time HRV feedback to enhance autonomic regulation, breathing techniques, and emotional self-regulation.
Eligibility
Sex
ALL
Min age
18 Years
Max age
55 Years
Healthy volunteers
Accepted
Inclusion Criteria:
1. Operational military personnel of the Guarda Nacional Republicana (GNR) performing security, patrol, criminal investigation, or road safety duties
2. Any military rank or professional category within operational roles
3. Age between 18 and 55 years, inclusive
4. Both males and females
5. Capable of providing informed consent in Portuguese language
Exclusion Criteria:
1. Extended sick leave or medical absence
2. Currently involved in serious disciplinary proceedings
3. Use, modification, or initiation of psychotropic medication (including antidepressants, anti-anxiety medications, antipsychotics, mood stabilizers) within the past 6 months
Primary outcome measure(s)
Change in Psychological Distress (Kessler Psychological Distress Scale - K10) — Baseline (Week 0), Post-intervention (Week 4), Follow-up (Week 10) The Kessler Psychological Distress Scale (K-10) is a 10-item self-report measure assessing psychological distress over the past 30 days. Items measure anxiety and depressive symptoms on a 5-point Likert scale (1=never to 5=always). Total score range: 10-50 (higher scores indicate greater distress). Portuguese validation: α=0.91. Primary outcome is change from baseline to post-intervention (week 4) and follow-up (week 10).
Change in Occupational Burnout (Burnout Assessment Tool - BAT-12) — Baseline (Week 0), Post-intervention (Week 4), Follow-up (Week 10) The Burnout Assessment Tool Short Form (BAT-12) is a 12-item self-report measure of occupational burnout across 4 dimensions: exhaustion (3 items), mental distance (3 items), cognitive impairment (3 items), emotional impairment (3 items). 5-point Likert scale (1=never to 5=always). Total score range: 12-60. Portuguese validation: α=0.85. Primary outcome is change from baseline to post-intervention and follow-up.
Change in Psychological Well-Being (WHO-5 Well-Being Index) — Baseline (Week 0), Post-intervention (Week 4), Follow-up (Week 10) The WHO-5 Well-Being Index is a 5-item self-report measure of psychological well-being over the past 2 weeks. Items assess positive mood, vitality, sleep, daily functioning, and life satisfaction on a 0-5 scale. Total score range: 0-25 (higher=higher well-being). Primary outcome is change from baseline to post-intervention and follow-up.
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.